NeuralCipher Open access
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases.
DOI: 10.3390/cells12131766PMID: 37443800
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
41.382 articles found
Open access
Are Therapies That Target α-Synuclein Effective at Halting Parkinson's Disease Progression? A Systematic Review.
DOI: 10.3390/ijms241311022PMID: 37446200
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Type, Timing, Frequency, and Durability of Outcome of Physical Therapy for Parkinson Disease: A Systematic Review and Meta-Analysis.
DOI: 10.1001/jamanetworkopen.2023.24860PMID: 37477916
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Longitudinal Meta-Analysis of Historical Parkinson's Disease Trials to Inform Future Trial Design.
DOI: 10.1002/mds.29514PMID: 37400277
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Aspartame use and Parkinson's disease: review of associated effects on neurotransmitters, oxidative stress, and cognition.
DOI: 10.1080/1028415x.2023.2228561PMID: 37395401
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Foslevodopa-Foscarbidopa (Vyalev): CADTH Reimbursement Recommendation: Indication: For the treatment of motor fluctuations in patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products
PMID: 37782736
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Molecular mechanisms underlying the neuroprotection of environmental enrichment in Parkinson's disease.
DOI: 10.4103/1673-5374.360264PMID: 36571341
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Considerations for developing a targeted amino acid supplement for people with Parkinson's disease that promotes health while accounting for pathophysiology and medication interference.
DOI: 10.1093/nutrit/nuad008PMID: 36809398
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
DOI: 10.1093/brain/awad063PMID: 36856727
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis.
DOI: 10.1093/aje/kwad082PMID: 37022311
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
New Insights into the Roles of p53 in Central Nervous System Diseases.
DOI: 10.1093/ijnp/pyad030PMID: 37338366
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Neurodegeneration and epigenetics: A review.
DOI: 10.1016/j.nrleng.2023.05.001PMID: 37344098
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.